关注
Ann Marie Navar
Ann Marie Navar
在 utsouthwestern.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review
BA Goldstein, AM Navar, MJ Pencina, JPA Ioannidis
Journal of the American Medical Informatics Association: JAMIA 24 (1), 198, 2017
8162017
Application of new cholesterol guidelines to a population-based sample
MJ Pencina, AM Navar-Boggan, RB D'Agostino Sr, K Williams, B Neely, ...
New England Journal of Medicine 370 (15), 1422-1431, 2014
7572014
Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence
SB Omer, WKY Pan, NA Halsey, S Stokley, LH Moulton, AM Navar, ...
Jama 296 (14), 1757-1763, 2006
5022006
Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges
BA Goldstein, AM Navar, RE Carter
European heart journal 38 (23), 1805-1814, 2017
4612017
Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease
AM Navar-Boggan, ED Peterson, RB D’Agostino Sr, B Neely, ...
Circulation 131 (5), 451-458, 2015
4082015
Apolipoprotein B particles and cardiovascular disease: a narrative review
AD Sniderman, G Thanassoulis, T Glavinovic, AM Navar, M Pencina, ...
JAMA cardiology 4 (12), 1287-1295, 2019
3782019
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of …
Writing Committee Members, SS Virani, LK Newby, SV Arnold, V Bittner, ...
Journal of the American College of Cardiology 82 (9), 833-955, 2023
3132023
Quantifying importance of major risk factors for coronary heart disease
MJ Pencina, AM Navar, D Wojdyla, RJ Sanchez, I Khan, J Elassal, ...
Circulation 139 (13), 1603-1611, 2019
2152019
Effectiveness of measles vaccination and vitamin A treatment
CR Sudfeld, AM Navar, NA Halsey
International journal of epidemiology 39 (suppl_1), i48-i55, 2010
2112010
Sex differences in the use of statins in community practice: patient and provider assessment of lipid management registry
MG Nanna, TY Wang, Q Xiang, AC Goldberg, JG Robinson, VL Roger, ...
Circulation: Cardiovascular Quality and Outcomes 12 (8), e005562, 2019
2022019
Patient‐reported reasons for declining or discontinuing statin therapy: insights from the PALM registry
CK Bradley, TY Wang, S Li, JG Robinson, VL Roger, AC Goldberg, ...
Journal of the American Heart Association 8 (7), e011765, 2019
1882019
Validation of the sleep regularity index in older adults and associations with cardiometabolic risk
JR Lunsford-Avery, MM Engelhard, AM Navar, SH Kollins
Scientific reports 8 (1), 14158, 2018
1552018
Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review
E Vynnycky, EJ Adams, FT Cutts, SE Reef, AM Navar, E Simons, ...
PloS one 11 (3), e0149160, 2016
1422016
Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel
P Muntner, PT Einhorn, WC Cushman, PK Whelton, NA Bello, PE Drawz, ...
Journal of the American College of Cardiology 73 (3), 317-335, 2019
1392019
Association of vaccine-related attitudes and beliefs between parents and health care providers
MJ Mergler, SB Omer, WKY Pan, AM Navar-Boggan, W Orenstein, ...
Vaccine 31 (41), 4591-4595, 2013
1372013
Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta‐analysis
SH Yedlapati, SU Khan, S Talluri, AN Lone, MZ Khan, MS Khan, ...
Journal of the American Heart Association 10 (6), e019636, 2021
1362021
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the …
A Khera, SJ Baum, TJ Gluckman, M Gulati, SS Martin, ED Michos, ...
American journal of preventive cardiology 1, 100009, 2020
1362020
Proportion of US adults potentially affected by the 2014 hypertension guideline
AM Navar-Boggan, MJ Pencina, K Williams, AD Sniderman, ED Peterson
Jama 311 (14), 1424-1429, 2014
1252014
Association of prior authorization and out-of-pocket costs with patient access to PCSK9 inhibitor therapy
AM Navar, B Taylor, H Mulder, E Fievitz, KL Monda, A Fievitz, JF Maya, ...
JAMA cardiology 2 (11), 1217-1225, 2017
1192017
Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the patient and provider assessment …
MG Nanna, AM Navar, P Zakroysky, Q Xiang, AC Goldberg, J Robinson, ...
JAMA cardiology 3 (8), 739-748, 2018
1062018
系统目前无法执行此操作,请稍后再试。
文章 1–20